Tamai H, Matsuo S, Fukatsu A, Nishikawa K, Sakamoto N, Yoshioka K, Okada N, Okada H
Third Department of Internal Medicine, Nagoya University School of Medicine, Japan.
Clin Exp Immunol. 1991 May;84(2):256-62. doi: 10.1111/j.1365-2249.1991.tb08158.x.
The 20-kD homologous restriction factor (HRF20), which is identical to CD59, is a membrane-associated protein which inhibits the reaction of C9 to form membrane attack complex (MAC) of homologous complements. In various human glomerular diseases deposition of complement components is frequently seen and MAC is reported to associate with immune deposits. Using a specific monoclonal antibody, 1F5, against HRF20, we attempted to study the localization of HRF20 in human glomerulonephritides and to compare the localization of HRF20 with those of immune deposits and MAC. The frozen sections of kidney specimens were fixed in acetone at room temperature before staining. In normal kidneys and kidney specimens from the patients with minimal change nephrotic syndrome, membranous nephropathy, and IgA nephropathy, HRF20 was strongly localized in the peritubular capillaries and along Bowman's capsules. A weaker but well-defined staining was obtained in the mesangial area and faint staining was seen along the glomerular capillary walls. In contrast, glomerular capillary walls were rather strongly stained in the cases with diffuse lupus nephritis which had subendothelial dense deposits. These data suggest that HRF20 (CD59) is present in the human glomeruli and its expression is enhanced under certain conditions such as lupus nephritis.
20kD同源限制因子(HRF20)与CD59相同,是一种膜相关蛋白,可抑制C9反应以形成同源补体的膜攻击复合物(MAC)。在各种人类肾小球疾病中,经常可见补体成分的沉积,并且据报道MAC与免疫沉积物相关。我们使用针对HRF20的特异性单克隆抗体1F5,试图研究HRF20在人类肾小球肾炎中的定位,并将HRF20的定位与免疫沉积物和MAC的定位进行比较。肾标本的冰冻切片在染色前于室温下用丙酮固定。在正常肾脏以及微小病变肾病、膜性肾病和IgA肾病患者的肾标本中,HRF20强烈定位于肾小管周围毛细血管和鲍曼囊周围。在系膜区获得较弱但明确的染色,在肾小球毛细血管壁可见淡染色。相比之下,在伴有内皮下致密沉积物的弥漫性狼疮性肾炎病例中,肾小球毛细血管壁染色相当强烈。这些数据表明,HRF20(CD59)存在于人类肾小球中,并且在诸如狼疮性肾炎等某些条件下其表达会增强。